Pfizer’s $13.5bn keeps US in health
Underlining the continuing robustness of the US high grade market, Pfizer raised $13.5bn of the $22.5bn it needs to repay the bridge loan taken out to buy Wyeth. While there was some dissension about the scale of the new issue concession, the bonds still came in like a train after pricing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts